Patents
Patents for C07H 17 - Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals (11,681)
02/2002
02/13/2002EP0912591B1 Novel method for isomerising the 10-methyl radical of erythromycin derivatives
02/13/2002CN1335881A UME extract having medicinal effects and compositions containing the same
02/13/2002CN1335131A Local administration preparation
02/12/2002US6346610 Reacting n-protected form of compound with methyl methanesulfonate or methyl p-toluenesulfonate in the presence of a base
02/07/2002WO2002010181A1 Azithromocin monohydrate with lower hygroscopicity, preparation method and pharmaceutical compositions which include it
02/07/2002WO2002010148A1 Novel coumarin derivatives and the salts thereof, a process for the preparation thereof and their use in the pharmaceutical field
02/07/2002WO2002009699A2 Method of treating symptoms of common cold, allergic rhinitis and infections relating to the respiratory tract
02/07/2002WO2002009640A2 Process for the preparation of anhydrous azithromycin
02/07/2002CA2417788A1 Novel coumarin derivatives and the salts thereof, a process for the preparation thereof and their use in the pharmaceutical field
02/06/2002EP0728138B1 Anthracycline derivatives
02/06/2002CN1334735A Ethanolate of azithromycin, process for manufacture, and pharmaceutical compositions thereof
02/06/2002CN1334269A Process for extracitng puerarin from waste water from producing puerarin starch and increasing its yield
02/05/2002US6344542 A polypeptides involved in signal transduction; therapy and diagnosis of cancers, diabetes, obesity, anorexia, asthma, parkinson's disease, heart disease, strokes, allergies, schizophrenia, huntington's disease and tourett's syndrome
02/05/2002CA2097840C Natamycin recovery
01/2002
01/31/2002WO2001060832A3 Pluraflavins and derivatives thereof, process for their preparation and use thereof
01/31/2002US20020013481 Use of flavones flavanones and flavonoids for protecting ascorbic acid and/or ascorbyl compounds from oxidation
01/31/2002US20020013468 Chemical intermediate for macrolactone antibiotic
01/31/2002US20020013454 Process which is useful for converting the carbonyl function in position 4" of the cladinose unit of an aza-macrolide into an amine derivative
01/31/2002US20020013281 11,12-Dideoxy-3-de((2,6-dideoxy-3-C-methyl-3-O-methyl-alpha-L -ribohexopyranosyl)oxy) 6-0-methyl 3-oxo-12,11-(oxycarbonyl) ((4-(4-(4-aminophenyl)-1H-imidazol-1-yl)-butyl)imino))-erythromycin; grampositive bacteria, esp. staphyloccus
01/30/2002EP1175502A1 Halo- or hydroxy-substituted nocathiacin antibiotics
01/30/2002EP1175429A1 Halo derivatives of 9-deoxo-9a-aza-9a-homerythromycin a
01/30/2002EP1175428A1 3-deoxy-desmycosin derivatives and process for their preparation
01/30/2002CN1333783A Macrolide intermediates in the preparation of clarithromycin
01/30/2002CN1333782A New derivatives of erythromycin, process for making them and use as medicaments
01/29/2002US6342590 Erythromycin a derivatives and method for preparing same
01/29/2002US6342244 Hydrophilic polymer covalently yet reversibly linked to a amine-containing ligand through a dithiobenzyl linkage; modification of various substrates, such as polypeptides, drugs and liposomes; upon cleavage of the linkage, the ligand
01/29/2002CA2245398C Azithromycin monohydrate isopropanol clathrate and methods for the manufacture thereof
01/24/2002WO2001060833A3 Motilide compounds
01/24/2002US20020010322 New aromatic derivatives substituted by a ribose, their preparation process and their use as medicaments
01/23/2002EP1174140A1 Skin preparations for external use
01/23/2002EP1173455A2 Novel ribose-substituted aromatic amides, method for the production and use thereof as medicaments
01/23/2002EP1173222A2 Conjugate having a cleavable linkage for use in a liposome
01/23/2002CN1332746A Novel derivatives from class of oleandomycin
01/22/2002US6340746 Thiolamine or selenolamine conjugate with antioxidant vitamin; nontoxic
01/22/2002CA2102457C Erythromycin derivatives, process for the preparation thereof, and use thereof as medicaments
01/17/2002WO2001041775A3 Use of procyanidins in the maintenance of vascular health and modulation of the inflammatory response
01/17/2002WO2001040242A3 6-o-methylerythromycin a crystal form iii
01/17/2002US20020007049 Ethanolate of azithromycin, process for manufacture, and pharmaceutical compositions thereof
01/16/2002EP1172109A1 Compositions for preventing and treating type i allergy
01/16/2002EP1171583A2 A multi-plasmid method for preparing large libraries of polyketides and non-ribosomal peptides
01/16/2002EP1171448A2 Macrolide antiinfective agents
01/16/2002EP1171447A2 Ketolide antibacterials
01/16/2002EP1171446A2 Macrolide antiinfective agents
01/16/2002EP0854879B1 Novel 5-o-deosaminyl 6-o-methyl erythronolide a derivatives, preparation method therefor and use thereof for preparing biologically active materials
01/16/2002CN1331697A Troxerutin with high trihydroxy-ethyl-rutin content and method for preparing same
01/16/2002CN1331601A Antiprotozoal saponins
01/16/2002CN1331078A 4-beta-amino-saccharidoid side chain-4-dehydro-4'-demethylpodoph-yllotoxin derivative with antineoplastic activity and its synthesizing process
01/10/2002US20020004487 Novel erythromycins and process for their preparation
01/09/2002EP1169328A2 Avermectin derivatives
01/09/2002EP0986569A4 Process for preparing etoposide
01/03/2002WO2002000663A2 Polycyclic xanthones as antibiotics
01/03/2002WO2000061549A3 Pharmaceutical compounds
01/03/2002US20020002176 Apomorphine and norapomorphine N-glucuronides, O-sulfates, O-glucuronides, N-sulfates, O-phosphates and N-phosphates, esters, ethers, and N-alkyls; sexual disorders and Parkinson's disease; bioavailability; side effect reduction
01/03/2002CA2412559A1 Polycyclic xanthones as antibiotics
01/02/2002EP1167376A1 Macrolide antibiotics
01/02/2002EP1167375A1 Erythromycin derivatives
01/02/2002EP1167357A1 Alpha-substituted carboxylic acid derivatives
01/02/2002EP1166643A1 Process for separating and recovering protein and isoflavones from a plant material
01/02/2002EP1165583A1 Method for reducing imidates to produce an 8a-azalide macrocycle
01/02/2002EP1165582A2 Novel method for the production of etoposide
01/02/2002EP1165581A1 Method for the production of 4'-demethyl - 4'-phosphate-2",3" - bis pentafluorophenoxyacetyl - 4",6"-ethylidene - beta-d- glucoside epipodophyllotoxin and the salts thereof
01/02/2002EP1165058A2 Use of azalide antibiotics for the topical treatment or prevention of ocular infections
01/02/2002CN1329616A Acylated benzylmal tosides as inhibitors of smooth muscle cell proliferaton
01/02/2002CN1329007A Preparation of clamycin 2'-monopropionate dodecylsulfate and its medicinal application
01/01/2002CA2085490C Processes for the manufacture of enriched pitches and carbon fibers
12/2001
12/27/2001WO2001097778A2 Amphotericin b structured emulsion
12/26/2001CN1328466A Use of antifungal agents for treating scleroses
12/25/2001CA2234164C Novel orthosomycins from micromonospora carbonacea
12/20/2001WO2000066602A9 3-deoxy-desmycosin derivatives and process for their preparation
12/19/2001EP1163250A2 Improved synthesis of [2.2.1]bicyclo nucleosides
12/19/2001EP0971717B1 Cytotoxic amino sugar and related sugar derivatives of indolopyrrolocarbazoles
12/13/2001WO2001040241A3 6-o-alkyl-2-nor-2-substituted ketolide derivatives
12/13/2001US20010051711 Form glucose and ascorbic acid; using anionic exchange resin
12/12/2001EP1162205A2 Process for producing 2-O-Alpha-D-Glucopyranosyl-L-ascorbic acid in high content
12/12/2001EP1161438A1 6-o-substituted macrolides having antibacterial activity
12/12/2001EP1161231A2 Method of inhibiting a chaperone protein
12/12/2001EP0900230B1 Esculetin derivatives
12/12/2001CN1326460A B-membered azalides and their use as antibiotic agents
12/12/2001CN1325686A Flavonoids used as anti-rejection agent
12/11/2001US6329345 13-membered azalides and their use as antibiotic agents
12/06/2001WO2001092341A1 Hexaglucal compound and the use and the methods of preparing them
12/06/2001WO2001092281A1 Method used for transforming the carbonyl function in position 4'' of a cladinose unit of an aza macrolide into an amine derivative
12/06/2001WO2001091758A1 Water-soluble amide derivatives of polyene macrolides and preparation and uses thereof
12/06/2001CA2410886A1 Water-soluble amide derivatives of polyene macrolides and preparation and uses thereof
12/05/2001EP1160252A1 Avermectin derivatives
12/05/2001CN1325452A Method for the preparation of quercetin and isoquercetin derivatives
12/05/2001CN1324954A Method for detecting flu A-type and B-type in clinic sample
12/04/2001CA2046880C Substituted alkylamide derivatives of teicoplanin
11/2001
11/29/2001WO2001025246A3 Chromogenic substrates of sialidase of bacterial, viral, protozoa, and vertebrate origin and methods of making and using the same
11/29/2001US20010047089 Dissolving azithromycin in acetone at 20-25 degrees C, adding water in two separate sequential additions, isolating the crystals of azithromycin dihydrate
11/29/2001US20010047088 Process for the preparation of 9-deoxo-8a-aza-(8a-alkyl)-8a-homoerythromycin A derivatives from 9-deoxo-9 (Z)-hydroxyiminoerythromycin A
11/29/2001US20010046963 Inhibiting cyclooxygenase-2 biosynthesis and Nuclear factor kappa B synthesis; treatment of arthritis and Alzheimer's disease; administering in food
11/28/2001EP0758244B1 Controlled-release dosage forms of azithromycin
11/27/2001US6323018 Used in therapy
11/27/2001CA2045864C Stable salts of 4"-deoxy-4" epi-methylamino avermectin bla/blb
11/22/2001WO2001087912A1 Polymorphic form of azithromycin dihydrate and preparation method thereof
11/22/2001WO2001087911A1 Method of identifying critical points within protein-protein interactions
11/22/2001WO2001087807A2 A cost effective method for selective methylation of erythromycin a derivatives
11/22/2001WO2001087309A1 Coumermycin analogs as chemical dimerizers of chimeric proteins
11/22/2001US20010043976 Solvent extraction of ginkgo biloba leaves including a deterpenation step using an aliphatic ester solvent.
1 ... 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 ... 117